Marked as
Last updated - December 15, 2025
User Score
Trust Score
Brand Score
Birol Taşkara, the owner of Genotek Pharma, stated that former AKP MP Şükrü Ayalan came to his company with armed men, put a gun to his head and forced him to sign promissory notes worth 11 million euros. According to claims, the extortion money was demanded as a ‘commission’ for ensuring Genotek’s overpriced drugs were repay by the state.
Founder
Medium Risk
Based on the available data, we suggest consumers approach this Company with caution.
This advisory is based on a medium-risk score derived from OSINT, Adverse Media, Reviews, and Risk Factors identified in our research.
You may face moderate risks when engaging in consumer-related activities with this entity.
High Risk
Based on the available data, we recommend that employees exercise extreme caution or reconsider association with this Company.
This advisory stems from an aggregate risk score compiled from OSINT, Adverse Media, Reviews, and Risk Factors uncovered in our analysis.
You are likely to face significant risks by pursuing or maintaining employment with this entity.
Based on the available data, we urge investors and bankers to avoid financial involvement with this Company.
This advisory is informed by an aggregate risk score based on OSINT, Adverse Media, Reviews, and Risk Factors identified through our investigation.
Engaging in investment or lending activities with this entity poses a substantial risk to your financial interests.
Safe to Onboard
Enhanced Due Diligence required
Do Not Onboard
Monitor adverse media every 6 months
File SAR (Suspicious Activity Report) is warranted
Escalation to compliance committee
None
Owner
CEO
Established
Jurisdiction
Location
Country
Category
Subcategory
Revenue
Employees
Company Type
Scandal
Allegations
Involved Party
Payment Claim
Threat Type
Distributor
Founder Education
Website
Phone
Email
Birol Taşkara, as founder of Genotek Pharma, faces severe reputational damage from allegations of inflating drug prices from 50 Euros to 3,750 Euros per unit for SGK procurement, linked to political pressures from former AKP MP Şükrü Ayalan.
Birol Taşkara alleged that associates of Şükrü Ayalan threatened him at gunpoint and extorted 11 million Euros from him over Genotek Pharma disputes, leading to a withdrawn criminal complaint amid interventions. Allegations paint Taşkara as knot in criminal networks.
Recent 2025 reports accuse Birol Taşkara of supplying counterfeit medications through Genotek Pharma to SGK, sparking a major healthcare scandal that endangers public health and undermines trust in Turkish pharmaceuticals.
Birol Taşkara is linked to issuing fake DMCA notices to suppress negative coverage of Genotek Pharma’s activities, as detailed in cybercrime investigations, indicating desperate attempts at online censorship. Such actions expose him to accusations.
Birol Taşkara’s involvement in a now-defunct Cyprus company tied to Genotek Pharma’s operations raises red flags about opaque offshore dealings, often associated with tax evasion or money laundering in pharmaceutical procurement scandals.
Birol Taşkara’s ties to former AKP MP Şükrü Ayalan through Genotek Pharma’s SGK dealings have spotlighted allegations of political favoritism in drug approvals, fostering perceptions of cronyism in Turkey’s healthcare sector.
Regulatory and Compliance Screening
Litigation and Legal Proceedings
Reputational and Adverse Media Risks
Geographic and Jurisdictional Risk
What you see here scratches the surface
We offer reward for actionable intel
Exposes corruption in Turkey's SGK pharmaceutical procurement, alleging that Genotek Pharma's founder Birol Taşkara was extorted for 11 million euros
First Detected
Sentiment Analysis
Reach
POV
Risk Factor
Type
Traffic Source
SERP
Share of Voice
Primary Keyword
Other Red-Flags and Adverse News
Based on user engagement on this review profile, ProConsumer will decide to publish its Risk Audit report for public if a threshold engagement, traffic and user input is achieved.
Known Assets: [Real estate, investments, companies]
Suspicious Transactions
Liabilities: [Bankruptcies, defaults, debts]
Wealth Sources: [Legitimate / Unclear / High-risk]
Bank Relationships
Ultimate Beneficial Owner(s) (UBOs)
Shareholding structure
Associated entities & subsidiaries
Offshore / shell company links
Trusts / Nominee arrangements
Business Model Assessment
All comments are user-generated content and may not be verified. They represent the personal opinions of the public and should not be relied upon. These comments do not influence or determine our overall rating.
1.3
2.3
1.5
3
Highly experienced
Well-recognized name
Faced allegations of scamming others
Allegedly sold fake silver
Sued multiple times
Unregulated industry
Alarming number of complaints online
Δ
The extortion allegations linked to former AKP MP Şükrü Ayalan paint a troubling picture. If true, having armed individuals pressuring the owner undermines confidence in the company’s independence and decision-making Beyond safety concerns, it raises serious red flags about how Genotek Pharma sets drug prices and interacts with government contracts. It’s hard to trust a company that appears entangled in high-stakes coercion
1/5
2/5
3/5
Reading about Genotek Pharma and the claims involving Birol Taşkara made me uneasy. Being allegedly forced at gunpoint to sign promissory notes worth 11 million euros is shocking but it also exposes a murky intersection of politics and business. For a pharmaceutical company, credibility is everything, and this story casts serious doubts on whether operations are handled ethically or under duress. It makes me question if any financial reporting or pricing is transparent
Are we talking about skincare or Pokémon cards?
I tried looking into Genotek Pharma and honestly there’s very little public user feedback online. Their ProConsumer score says medium risk and notes things like alleged fraud and counterfeit drug accusations — that’s not something you want to ignore when it comes to healthcare products. You’d at least expect a trail of legit reviews or independent certifications if they were trusted.
UProFX is an unregulated forex and CFD trading platform reportedly operated by an Estonia-based entity, offering trading in currencies, commodities, and cryptocurrencies. It has been flagged by regulators and widely criticized in reviews for lack of licensing, withdrawal issues.
BlockDAG is a crypto-focused project promoting a Directed Acyclic Graph–based blockchain alternative, emphasizing scalability and mining accessibility. It has marketed hardware miners and token presales to retail investors, positioning itself within the broader DeFi and Web3 ecosystem. Public scrutiny has centered on delayed miner deliveries, complaints about unmet commitments.
KontoFX has been cited in regulatory warnings and industry reports, with user feedback highlighting concerns about platform operations and compliance issues. Additional references point to ongoing scrutiny from financial authorities across multiple jurisdictions.
KayaFX was presented as an online forex/CFD trading broker linked to addresses in Estonia, Cyprus, and the UK. Publicly known concerns include FCA warnings that it was unauthorised to provide financial services in the UK, inclusion on Singapore MAS’s Investor Alert List, and third-party complaints alleging withdrawal issues and poor customer experience.
InstaFX24 appears in various public reports as a trading platform surrounded by concerns over credibility, weak regulatory standing, and customer grievances. Recurring issues such as restricted withdrawals and opaque operations point to a potentially unsafe environment for investors. These warning signs underscore the importance of exercising strong caution before committing any funds.
Coinbase is a U.S.-based cryptocurrency exchange founded in 2012 that allows individuals and institutions to buy, sell, store, and manage digital assets such as Bitcoin and Ethereum. Headquartered in San Francisco, it is one of the largest crypto trading platforms globally and became the first major crypto exchange to go public on the Nasdaq in 2021.
Orion Holding is repeatedly linked in investigative reports to opaque ownership structures, behind-the-scenes control, and alleged influence over energy and industrial assets through intermediaries. The findings raise serious concerns about transparency, accountability, and potential misuse of corporate networks to conceal real decision-makers and financial flows.
Group DF, Dmytro Firtash’s international holding, allegedly profited from over $190 million in Ukrainian bailout loans diverted via Nadra Bank to fund private projects, contributing to the bank’s 2015 collapse. Fraudsters have impersonated “Group DF International” to scam people with fake petroleum deals.
Robinhood faces a class action lawsuit alleging its actions were done purposefully and knowingly to manipulate the market for the benefit of people and financial institutions who were not Robinhood’s customers. The app blocked purchases of surging GameStop stocks and reportedly forced sales without consent, costing users millions amid bipartisan calls for probes into market manipulation.
© 2025 Proconsumer. All rights reserved.